An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

NCT07371663 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Cancers
NSCLC (Advanced Non-small Cell Lung Cancer)
Gastric (Stomach) Cancer
Endometrial Cancer
Malignant Melanoma

Interventions

DRUG: TCC1727 tablet 90mg
DRUG: TCC1727 tablet 120mg
DRUG: TCC1727 tablet 160mg
COMBINATION_PRODUCT: benmelstobart Injection

Sponsor

Beijing Tide Pharmaceutical Co., Ltd